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Abstract
Objective: Accurate automated segmentation of cartilage should provide rapid reliable outcomes for 
both epidemiological studies and clinical trials. We aimed to assess the precision and responsiveness 
of cartilage thickness measured with careful manual segmentation or a novel automated technique. 
Methods: 
Agreement of automated segmentation was assessed against two manual segmentation datasets: 379 
MR images manually segmented in-house (Training  set), and 582 from the OAI with data available at 
0, 1, and 2 years (Biomarkers set).  Agreement of mean thickness was assessed using Bland-Altman 
plots, change with pairwise Students t-test, in the central medial femur and tibia regions (cMF, cMT). 
Repeatability was assessed on a set of 19 knees imaged twice on the same day. Responsiveness was 
assessed using standardised response means (SRMs).  
Results: 
Agreement of manual vs automated methods was excellent with no meaningful systematic bias 
(Training set cMF bias 0.1mm 95%CI ±0.35, Biomarkers set bias 0.1mm ±0.4). The smallest detectable 
difference (SDD) for cMF was 0.13mm, coefficient of variation (CoV) 3.1%; cMT 0.16 mm, 2.65%.  
Reported change using manual segmentations in the cMF region at 1 year was -0.031mm, confidence 
limit (-0.022, -0.039), p<10-4, SRM -0.31 (-0.23,-0.38); at 2 years was -0.071 (-0.058,-0.085), p<10-4, 
SRM -0.43(-0.36,-0.49). Reported change using automated segmentations in the cMF at 1 year was -
0.059 (-0.047, -0.071), p<10-4, SRM -0.41(-0.34,-0.48) ; 2 years: -0.14 (-0.123,-0.157), p<10-4, SRM -0.67 
(-0.6,-0.72).  
Conclusion: A novel cartilage segmentation method provides highly accurate and repeatable 
measures with comparable cartilage thickness measurements to careful manual segmentation, but 
with improved responsiveness.  
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Introduction
Cartilage is a key tissue of interest in structure-modification trials of osteoarthritis (OA). Although 
radiographic joint space width, a surrogate for cartilage loss, is the regulatory endpoint in these trials 
there is increasing evidence of the benefits of direct measures of cartilage morphology using 
magnetic resonance imaging (MRI)(1).  
Techniques employing manual segmentation of cartilage have been explored with respect to a 
number of morphological characteristics, including volume and thickness, and extensively validated, 
including construct validity against radiographic joint space width, predictive and concurrent validity, 
and clinical outcomes  (2-5). MRI cartilage thickness measures are associated with OA progression 
and joint replacement, and provide more responsive measures of progression than radiographic 
joint space narrowing (JSN) (5-7)
However, manual segmentation of cartilage morphology is time-consuming, tedious and challenging 
as careful attention must be paid to detecting the eroding outer margin of the cartilage. It therefore 
takes considerable time (hours) to carefully segment a single MR image, being composed in this case 
of 160 slices, limiting the utility of the method in analysing large datasets such as the Osteoarthritis 
Initiative (OAI), which includes data from over 9,000 knees at multiple time points.  Additionally, the 
average amount of cartilage lost on each bone in the medial tibiofemoral joint of an OA knee is very 
small, typically around 50  100 microns per annum.  This equates to a change of around 1/5 to 1/10 
of a pixel in a typical MR image. To improve the speed of segmentation, some techniques for 
analysis have incorporated varying degrees of user input into semi-automated cartilage 
assessment(8).  
Fully automated segmentation is desirable but the reliability and responsiveness of any such 
methods need to be established in a method that does not rely upon any user interaction. Fully 
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automated methods based on active appearance modelling (AAM) have demonstrated good 
measurement accuracy for a number of MRI-assessed tissues including knee cartilage, bone area and 
bone shape (9, 10)  The addition of supervised machine learning to the AAM methodology offers 
potential enhancement in terms of improved voxel classification resulting in improved accuracy and 
responsiveness. A previous exercise used a preliminary version of this technology (10) but utilised a 
training set that had relatively crude manual segmentation, was not widely reflective of an OA 
population, used different MRI sequences to those in this study (making it impossible to run the 
older technology on the new dataset), and contained no longitudinal data.
In this study, we examined the performance metrics of a novel extension of AAM technology which 
incorporated a final refinement stage using supervised machine learning (AQ-CART). We assessed 
mean cartilage thickness in the anatomical locations which are commonly used in OA studies; we 
examined the accuracy and reliability of the method, agreement with careful manual segmentation 
and relative responsiveness. 
Method
A number of comparisons were used in this study.  For convenience, a summary of the datasets 
used, and the analyses performed are provided in Table 1. 
Patients and Imaging
Image selection
A training set of 379 patient single-knee MRI images (the Training setwere used as input data for 
the supervised machine learning step of AQ-CART. These were selected to represent the entire range 
of radiographic OA structural severity, including medial compartment Kellgren-Lawrence grades 0-4, 
lateral compartment OA, together with young healthy knees which tend to have thicker cartilage. 
287 images were acquired using a 3D double-echo-in-steady-state sequence (DESS-we) from the OAI 
(voxel size 0.3 x 0.3 x 0.7mm), but were not members of the Biomarkers set.  92 images were 
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acquired using a Philips 3D T2* weighted 3D gradient-echo sequence with water excitation (voxel 
size 0.3 x 0.3 x 1.5mm).   The AAM training set has been described previously (11, 12).
Repeatability was performed on the Repeatability image set, a group of 19 subjects with and without 
radiographic OA that had test-retest single knee images acquired as a pilot study for the OAI (13). 
For agreement and responsiveness, we used patient datasets from the OA Biomarkers Consortium 
FNIH sub-study of the OAI (https://oai.epi-ucsf.org/datarelease/FNIH.asp). Of 600 patients in the 
study, 582 patient datasets had manual cartilage measurements (Biomarkers image set) recorded at 
baseline, 1 and 2 years, resulting in sub-groups of 196 non-progressors and 386 progressors for 
either pain or structure or both, according to the FNIH subgroups. All images employed in these 
analyses used the Dual Echo Steady-State (DESS) MRI sequence: Additional parameters of the full 
OAI pulse sequence protocol and sequence parameters have been published in detail (14).
Ethics Approval
The OAI study received ethical approval from the UCSF OAI Coordinating Center IRB number 10-
00532, reference 210064, Federalwide Assurance #00000068, and the OAI Clinical Sites Single IRB of 
Record was for study number 2017H0487, Federalwide Assurance #00006378.  All patients provide 
informed consent to the OAI.  Some of the Training set were collected under a study approved by 
the ethics committee of Lund University (LU-535)
Selection of regions for comparison
A number of anatomical regions of cartilage were provided on the OAI website  for convenience we 
chose the regions usually considered the most responsive  the central medial femur (cMF) and 
central medial tibia (cMT) (15) 
(https://oai.epiucsf.org/datarelease/SASDocs/kMRI_FNIH_QCart_Chondrometrics_Descrip.pdf).  The 
mean thickness measure (ThCtAB) from each region was compared with the mean thickness from 
the automated segmentation. For automated segmentation, regions were selected on the mean 
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shape model to match the anatomical definition used for the manual method (Figure 1A).  For 
reference the variable names of the baseline cartilage measures for the manual method were 
V00BMFMTH (cMF.ThCtAB) and V00CMTMTH (cMT.ThCtAB). 
Manual segmentation method  Biomarkers dataset
Cartilage thickness was measured in the Biomarkers image set, using manual segmentation of the 
femorotibial cartilage surfaces by experienced segmenters, and reviewed by an expert as has been 
described previously ((16, 17),Chondrometrics GmBH). 
Manual segmentation and surface building  Training dataset
For the supervised learning algorithm training set, cartilage was manually segmented by experienced 
segmenters, using Imorphics EndPoint software (Imorphics, Manchester, UK) using the Training 
image set.  3D surfaces were generated from the cartilage contours in each image slice using a 
marching cubes algorithm, followed by geometric smoothing.
AQ-CART method
Each image was automatically segmented using 3D AAMs of bone and cartilage using a multi-start 
optimisation.  Active appearance models are widely used in medical imaging, and fit the shape and 
grey-level variations of a training set to a 3D image, and are capable of rapid and accurate 3D 
segmentation, with sub-voxel accuracy (18).  Initially, this P low-density low-resolution deformable 
models but ends in a robust matching of detailed high-resolution models. Finally, in a novel step, the 
voxels contained in the cartilage region are assigned with a nonlinear regression function, based on 
a bootstrap aggregation, chosen using a probably approximately correct (PAC) learning method.
Cartilage thickness was measured using the Anatomically Corresponded Regional Analysis of 
Cartilage (ACRAC) (11, 19), which is summarised in Figure 1B.  From each correspondence point on 
the 3D bone surface, which is the result of an AAM bone search, we measure the distance from the 
bone to the outer cartilage surface, along a line normal to the bone surface. In addition to providing 
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accurate and repeatable measurement, this process fits all examples with a consistent dense set of 
anatomical landmarks, which can be used to take a measurement at the same point across a 
population and between time points, correcting for both the size and shape of each bone.
Accuracy, reliability and comparative analyses
Accuracy of AQ-CART was determined using the Training image set, using leave-25%-out models.  In 
this method, 4 models are built, each of which leaves out 25% of the training examples.  Each image 
is then searched using the single model which does not contain itself as a training example.  This 
means that each image is searched using an unbiased model.
ACRAC cartilage thickness maps (Figure 1C) were then prepared for both manual and automated 
segmentations and used to calculate the mean thickness within each region.  Correlation and 
agreement of the mean thickness measure was assessed using least-squares linear fits and Bland-
Altman plots.
Repeatability of AQ-CART was assessed on the Repeatability set, using the smallest detectable 
difference (SDD) defined as the 95% confidence interval (CI) on the Bland-Altman plot, and the 
coefficient of variation (CoV) using the root-mean-square method. 
Agreement of the mean thickness reported by the manual and automated segmentation methods 
using the baseline images of the Biomarkers image set was assessed using Bland-Altman plots. We 
then compared change from baseline of both methods using pairwise student t-tests of mean 
thickness of the central medial femur and tibia (cMF and cMT) in the 582 knees. Agreement of 2-
year change from baseline, as reported by the manual and automated segmentation methods, was 
assessed using a Bland Altman plot.   Responsiveness was assessed using standardised response 
means (SRMs). Confidence limits for the SRMs were calculated using a bootstrap method (MedCalc 
Software, Ostend, Belgium). Results were calculated separately for the 4 FNIH Biomarkers 
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subgroups, which were JSN progressors, pain progressors, combined JSN and pain progressors, and 
non-progressors [5]
Results
Correlation and agreement mean cartilage thickness using the Training set.
Correlation of the mean thickness reported by the manual and automated methods was r2 = 0.97 for 
the cMF region, and 0.84 for the cMT.  The equation for the linear least squares fit between the manual 
and automated methods for the cMF region was y = 0.81x + 0.44; for the cMT region was y = 0.81x + 
0.35 (Figure 2, top row). The automated segmentation had a small tendency to under-segment thicker 
cartilage and over-segment thinner cartilage, when compared with the Training set.  Systematic bias 
for the cMF region was 0.098 mm, 95% limits of agreement were 0.354 mm; for the cMT region bias 
was -0.026 and 95% limits of agreement were 0.420 (Figure 2, bottom row).
Repeatability 
The smallest detectable difference (SDD) in the Repeatability image set for the cMF region was 
0.13mm, coefficient of variation (CoV) 3.1%; for the cMT region the SDD was 0.16 mm, CoV 2.65% 
(Bland Altman plot not shown)
Agreement between baseline manual segmentations (Biomarkers set)
Systematic bias of the mean thickness reported by the manual and automated methods for the cMF 
region at baseline was +0.09mm, 95% confidence limits were ±0.35mm; for the cMT region bias was 
-0.2mm, 95% confidence limits were ±0.39mm (Figure 3)
Agreement of 2-year change (Biomarkers set)
In the Biomarkers set of 582 knees, the reported change in mean thickness measured with 
automated segmentation was around twice that reported by that with manual segmentation.  SRM 
values were also higher for the automated method.  For example, change in manual cMF at 1 year 
was -0.031mm, 95% confidence limit (-0.022, -0.039), p<10-4, SRM -0.31 (-0.23,-0.38); at 2 years this 
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was -0.071 (-0.058, -0.085), p<10-4, SRM -0.43 (-0.36,-0.49). Change in automated cMF at 1 years 
was -0.059 (-0.047, -0.071), p<10-4, SRM -0.41 (-0.34,-0.48); at 2 years change was- 0.14 (-0.123, -
0.157), p<10-4, SRM -0.67 (-0.6,-0.72) (Figure 4).  
The detection of greater change with the automated method was consistent in both of the joint 
space narrowing subgroups (Figure 1); additionally, the automated method detected a significant 
change in cartilage thickness at both timepoints in those who did not progress with either pain or 
joint space narrowing.  Neither method showed any change in those who progressed only in their 
pain score. Detailed results for all subgroups of femur and tibia using manual and automated 
methods is shown in Table 2
Time required for automatic analysis
Automatic segmentation of a single image, using a single CPU core of a PC, took on average 45 
seconds, and calculation of cartilage thickness and volume required a further 7 seconds.
Discussion
The novel automated segmentation technique reported here demonstrated excellent accuracy and 
reliability in assessing cartilage thickness in the medial tibiofemoral joint, the most commonly used 
region assessed in clinical trials. There was also excellent agreement with both cross-sectional 
measurement and longitudinal change in cartilage thickness when compared with a well-established 
manual segmentation method.
The agreement of automated segmentation measurements using the Training set was excellent with 
no meaningful systematic bias. The automated segmentation had a small tendency to under-
segment the thickest cartilage, and to over-segment denuded cartilage when compared with the 
Training set.  . In the central medial femur, cartilage with mean thickness of 3mm (approximately the 
95th percentile of cartilage thickness distribution in the training set) would be under-segmented by 
0.25mm, or about half of the average length of a voxel edge.  Completely denuded cartilage (mean 
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thickness of 0mm) would be over-segmented by 0.44m. Repeatability of the automated method 
(SDD of around 0.14mm, and CoV of 2.5 and 3.1%) was excellent, and comparable with values 
reported for manual segmentation methods (11, 13)
When comparing automated segmentation with the careful manual segmentation method of 
another group in the Biomarkers dataset, the automated method reported a slightly thicker average 
measure than the manual method of about 0.1mm.  This small difference is not particularly 
surprising for a few reasons: the 2 measures are calculated in very different ways; the regions to be 
measured were prepared independently; and the manual segmentation of the automated training 
set and manual set were also prepared independently.  However, despite these differences in 
methodology, the agreement between the two methods was excellent, as illustrated by the Bland 
Altman plot. 
The correlation of longitudinal change in the femur and tibia for the Biomarkers set was excellent, 
although the correlation of tibia measures was lower (0.87 vs 0.95 for the femur).  We cannot be 
certain of why the tibia has a lower correlation; as noted above, the methodologies are different, 
and both correlation coefficients are acceptable.
We did not perform a correlation of the individual longitudinal changes, as these would not be 
expected to correlate, given the amount of change found here, and the reported measurement 
errors of the methods. Given 2 methods, with measurement SD of 0.075 mm (approximately the SD 
for the two methods, and a test set which contains changes of between 0 and 0.15mm (the 
approximate range of annual changes found here), the correlation of the 2 methods will be very low 
(less than 0.02) assuming perfect agreement between the methods.  Any single measurement will 
contain the actual change, plus a normally-distributed error ranging from -0.14 mm to +0.14mm (the 
95th percentile, or 1.96 x SD).  Most of the differences found are dominated by noise, and do not 
reflect true change.  In a larger group, these differences in noise cancel each other out.
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Automated segmentation of tissues which change by small fractional amounts are often insensitive 
to any such change; such methods are often repeatable because of regression to the mean during 
the automated search. This causes potential over-segmentation of thin cartilage, and under-
segmentation of thick cartilage.  However automated segmentation with AQ-CART was at least as 
sensitive to change as careful manual segmentation, and this responsiveness was seen across the 
clinical progression subgroups. Additionally, the Non-Progressor group demonstrated significant 
cartilage thickness loss at both 1 and 2 years with the automated method, whereas no change was 
measured using the manual method.
The improved responsiveness was a consequence of the automated method identifying about twice 
as much change (in the femur), with similar levels of measurement noise. A typical amount of 
average cartilage thickness loss is tiny, much less than one voxel width in a year.  This means that 
cartilage loss is fundamentally a change in what becomes a partial volume in an MR image sampling 
voxel at the outer edge of the cartilage.  Human measurement is not capable of dealing with these 
partial volumes and It is likely that a human reader at a standard computer display cannot 
adequately resolve such differences in partial volume, whereas an algorithm can. All measurement 
methods contain errors, and there is no ground truth in this study, such as an independent 
measure of cartilage thickness using more accurate methods; it is not possible to be certain that 
improved responsiveness is certainly caused by cartilage changing by an additional 50 microns per 
year.
The short time required for analysis of an image (52 seconds), compared with the preparation of a 
manual segmentation (typically around 4 hours for our in-house segmenters), allows for the 
segmentation of large numbers of images.  In actuality, this time is shorter; 52 seconds are required 
for a single CPU core of a PC; however a typical desktop machine can run 8 threads simultaneously, 
reducing the average time for a single segmentation to around 10 seconds per image, with no 
requirement for user input.
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A potential limitation of this work was that the models were trained and tested on on 2 particular 
MRI sequences, and these were obtained using the same manufacturers and models of MRI 
machines, from an observational study in which image quality was tightly controlled.   The accuracy, 
repeatability and responsiveness of these models may not provide the same results when using 
other MR imaging sequences.  
In summary, application of a novel AAM-based cartilage segmentation incorporating a supervised 
machine learning step provided highly accurate and repeatable measurement of cartilage thickness 
with excellent agreement with careful manual segmentation, but with improved responsiveness.  
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Figure and Table Legends
Figure 1: Measurement Methodology
Figure (A) shows the selected regions of the central medial femur (cMF, top) and the central medial 
tibia (cMT, bottom).   Each correspondence point within the shape model is shown as a red sphere 
on the surface of the mean bone shapes; there are 1527 correspondence points in the cMF region, 
and 828 in the cMT regions. Figure (B) schematically shows the method by which cartilage thickness 
is measured using the Anatomically Corresponded Regional Analysis of Cartilage (ACRAC) method.  
From each correspondence point the distance along a line normal to the surface, and the distance 
from the bone to the outer cartilage surface is recorded (note normals are shown schematically, all 
in the same direction  in practise normal direction varies slightly with the curvature of the bone 
surface). Figure (C) shows typical examples of cartilage thickness in the femur of a healthy knee 
(left), and an OA knee (right).  Note that the OA knee is denuded in part of the cMF region (dotted 
green line)
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Figure 2: Correlation and agreement of mean thickness in the Training set
Top graphs show a scatter plot of mean thickness values, comparing reported mean thickness values 
for manual and automated segmentations in the Training set, using miss-25%-out models, for the 
cMF region (left) and cMT region (right), together with the results of a linear fit, plus the r-squared 
value for the correlation of the datasets.  The same data is displayed in the lower graphs using a 
Bland Altman plot to assess agreement; bias is shown with a thickly dashed line, and the 95th 
percentile confidence limits are shown using a dotted line
Figure 3: Agreement of mean cartilage thickness in the Biomarkers set 
Systematic bias is shown with a thickly dashed line, and the 95th percentile confidence limits are 
shown using a dotted line for the central medial femur (left) and central medial tibia (right)
Figure 4:  Graphical representation of 2-year change in central medial femur region by FNIH 
Biomarkers Subgroup
Results are shown for all 582 knees (All), together with the 4 subgroups; joint space narrowing 
progressors (JSN Only Progressor, n=102), both joint space narrowing and pain progressors (JSN 
and Pain Progressors, n=183), pain progressors (Pain Only Progressors, n=101), and non-
progressors (No JSN or Pain Progression, n=196). Further detail is provided in Table 2, along with 
results for the central medial tibia.  Error bars represent 95% confidence intervals.
Table 1:  Datasets and analysis methods used in this study
Key to 4 subgroups; joint space narrowing progressors (JSN Only Progressors), both joint space 
narrowing and pain progressors (JSN and Pain Progressors), pain progressors (Pain Only 
Progressors), and non-progressors (No JSN or Pain Progressors). 
Table 2:  Comparison of 1-year and 2-year change in cartilage thickness from baseline in the 
Biomarkers set
Results are shown for all 582 knees (All), together with the 4 subgroups; joint space narrowing 
progressors (JSN, n=102), both joint space narrowing and pain progressors (JSN and Pain, 
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n=183), pain progressors (Pain, n=101), and non-progressors (Non-Progressors, n=196). SRM 
95% confidence limits were estimated using a bootstrap method.
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 Figure 1:  Measurement Methodology 
Figure A shows the selected regions of the central medial femur (cMF, top) and the central medial tibia 
(cMT, bottom).   Each correspondence point within the shape model is shown as a red sphere on the surface 
of the mean bone shapes there are 1527 correspondence points in the cMF region, and 828 in the cMT 
regions 
(B) Schematically shows the method by which cartilage thickness is measured using the Anatomically 
Corresponded Regional Analysis (ACRAC) method..  From each correspondence point the distance along a 
line normal to the surface, and the distance from the bone to the outer cartilage surface is recorded (note 
normals are shown schematically, all in the same direction  in practise normal direction varies slightly with 
the curvature of the bone surface) 
(C) Shows typical examples of cartilage thickness in the femur of a healthy knee (left), and an OA knee 
(right).  Note that the OA knee is denuded in part of the cMF region 
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 Figure 2: Correlation and agreement of mean thickness in the Reference set 
Top graphs show a scatter plot of mean thickness values, comparing reported mean thickness values for 
manual and automated segmentations in the Reference set, using miss-25%-out models, for the cMF region 
(left) and cMT region (right), together with the results of a linear fit, plus the r-squared value for the 
correlation of the datasets. The same data is displayed in the lower graphs using a Bland Altman plot to 
assess agreement; bias is shown with a thickly dashed line, and the 95th percentile confidence limits are 
shown using a dotted line 
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 Figure    Agreement of mean cartilage thickness in the Biomarkers set 
Sstematic bias is shown with a thickly dashed line, and the 95th percentile confidence limits are shown 
using a dotted line for the central medial femur (left) and central medial tibia (right) 
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 Figure  Graphical representation of 2-year change in central medial femur region by FNIH Biomarkers 
Subgroup 
Results are shown for all 582 knees (All), together with the 4 subgroups; joint space narrowing 
progressors (JSN Only Progressor, n=102), both joint space narrowing and pain progressors (JSN and 
Pain Progressors, n=183), pain progressors (Pain Only Progressors,n=101), and non-progressors (No 
JSN or Pain Progression, n=196). Further detail is provided in Table 2, along with results for the central 
medial tibia. 
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Table 1:  Datasets and analysis methods used in this study
Image Dataset Dataset Segmentation of Cartilage 
Surfaces
Calculation of Cartilage Thickness Used For
Training 379 segmentations of femur and 
tibial cartilage at a single time point, 
on fat-saturated 3D MR images
Range of radiographic OA structural 
severity, including medial 
compartment Kellgren-Lawrence 
grades 0-4, lateral compartment OA, 
plus young healthy knees 
Manual segmentation using EndPoint 
(Imorphics), supervised by 
experienced segmenter (1)
Anatomically Corresponded 
Regional Analysis of Cartilage 
Thickness (ACRAC).  
Thickness is measured at multiple 
points along normals from the bone 
surface (Figure 1B,(2))
Training set for supervised machine 
learning step in AQ-CART
Correlation and agreement of mean 
cartilage thickness in cMF and cMT 
regions, automated or manual 
segmentations, miss-25%-out 
models
Repeatability 19 test-retest images of knees with 
and without radiographic OA - pilot 
study for the OAI (3)
n/a ACRAC Repeatability of automated 
segmentation
Biomarkers 582 segmentations of femur and 
tibial cartilage at baseline, 1 and 2 
years
JSN Only Progressors, n=102
JSN and Pain Progressors, n=183)
Pain Only Progressors, n=101)
No JSN or Pain Progression, n=196)
Manual segmentation by 
Chondrometrics, supervised by 
experienced segmenter (4, 5)
Volume of cartilage divided by region 
of bone ((5))
Cross-sectional agreement of mean 
cartilage thickness in cMF and cMT 
regions, using automated or manual 
segmentation, baseline images only
Longitudinal agreement of change in 
mean cartilage thickness from 
baseline in the same regions, using 
automated or manual segmentation
Responsiveness of automated and 
manual segmentation in the same 
regions using pairwise Students t-
test and SRM
Key to 4 subgroups; joint space narrowing progressors (JSN Only Progressors), both joint space narrowing and pain progressors (JSN and Pain Progressors), pain 
progressors (Pain Only Progressors), and non-progressors (No JSN or Pain Progressors). 
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Table 2:  Comparison of 1-year and 2-year change in cartilage thickness from baseline in the Biomarkers set
1year change from baseline 2-year change from baseline
FNIH Biomarkers 
Group
Mean Change [95% CL] SRM [95% CL] p-value Mean Change [95% 
CL]
SRM [95% CL] p-value
Femur Change (cMF region)
All  Manual -0.031 [-0.022,-0.039] -0.31 [-0.23,-0.38] 5.797E-13 -0.071 [-0.058,-0.085] -0.43 [-0.36,-0.49] 9.72E-23
All  Automated -0.059 [-0.047,-0.071] -0.41 [-0.34,-0.48] 8.330E-22 -0.14 [-0.123,-0.157] -0.67 [-0.6,-0.72] 2.54E-48
JSN Manual -0.059 [-0.033,-0.084] -0.45 [-0.28,-0.6] 1.320E-05 -0.136 [-0.099,-0.173] -0.74 [-0.59,-0.89] 4.07E-11
JSN Automated -0.092 [-0.056,-0.128] -0.5 [-0.32,-0.67] 1.620E-06 -0.236 [-0.184,-0.288] -0.9 [-0.73,-1.05] 9.10E-15
JSN and Pain Manual -0.055 [-0.039,-0.07] -0.5 [-0.34,-0.63] 1.228E-10 -0.128 [-0.102,-0.154] -0.73 [-0.62,-0.83] 9.72E-23
JSN and Pain Automated -0.074 [-0.052,-0.097] -0.48 [-0.36,0.6] 8.330E-22 -0.209 [-0.177,-0.241] -0.96 [-0.82,-1.09] 2.54E-48
Pain Manual -0.008 [0.009,-0.026] -0.1 [0.1,-0.28] 3.398E-01 -0.023 [0.017,-0.063] -0.12 [0.08,-0.24] 2.63E-01
Pain Automated -0.036 [-0.016,-0.057] -0.35 [-0.16,-0.52] 6.703E-04 -0.04 [-0.012,-0.068] -0.28 [-0.06,-0.43] 5.97E-03
Non-Progressors Manual -0.005 [0.004,-0.014] -0.07 [0.07,-0.21] 3.057E-01 -0.01 [0.001,-0.021] -0.13 [0.01,-0.27] 7.98E-02
Non-Progressors Automated -0.039 [-0.023,-0.056] -0.33 [-0.2,-0.45] 6.924E-06 -0.077 [-0.056,-0.098] -0.52 [-0.4,-0.62] 1.14E-11
Tibia Change (cMF region)
All  Manual -0.036 [-0.026,-0.045] -0.3 [-0.23,-0.38] 2.264E-12 -0.073 [-0.059,-0.086] -0.43 [-0.35,-0.49] 1.14E-22
All  Automated -0.055 [-0.043,-0.067] -0.39 [-0.31,-0.45] 1.829E-19 -0.114 [-0.097,-0.131] -0.55 [-0.48,-0.61] 3.21E-35
JSN Manual -0.057 [-0.03,-0.084] -0.42 [-0.22,-0.6] 4.223E-05 -0.117 [-0.083,-0.15] -0.7 [-0.52,-0.85] 3.17E-10
JSN Automated -0.08 [-0.05,-0.11] -0.52 [-0.33,-0.72] 7.201E-07 -0.179 [-0.132,-0.225] -0.76 [-0.58,-0.91] 1.43E-11
JSN and Pain Manual -0.05 [-0.03,-0.07] -0.37 [-0.23,-0.49] 1.287E-06 -0.117 [-0.088,-0.146] -0.6 [-0.47,-0.7] 1.14E-22
JSN and Pain Automated -0.068 [-0.043,-0.093] -0.4 [-0.26,-0.51] 1.829E-19 -0.172 [-0.137,-0.207] -0.72 [-0.6,-0.82] 3.21E-35
Pain Manual -0.025 [-0.006,-0.045] -0.26 [-0.06,-0.45] 9.860E-03 -0.03 [0.009,-0.069] -0.16 [0.07,-0.26] 1.23E-01
Pain Automated -0.037 [-0.018,-0.057] -0.38 [-0.2,-0.54] 2.170E-04 -0.035 [-0.008,-0.062] -0.26 [-0.06,-0.42] 1.05E-02
Non-Progressors Manual -0.016 [-0.002,-0.031] -0.16 [-0.03,-0.31] 2.792E-02 -0.03 [-0.015,-0.045] -0.29 [-0.15,-0.44] 9.56E-05
Non-Progressors Automated -0.039 [-0.022,-0.056] -0.32 [-0.19,-0.44] 1.056E-05 -0.067 [-0.044,-0.089] -0.42 [-0.3,-0.52] 2.01E-08
Results are shown for all 582 knees (All), together with the 4 subgroups; joint space narrowing progressors (JSN, n=102), both joint space narrowing and pain 
progressors (JSN and Pain, n=183), pain progressors (Pain, n=101), and non-progressors (Non-Progressors, n=196). SRM 95% confidence limits were estimated using a 
bootstrap method.
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